Journal
VACCINE
Volume 28, Issue 27, Pages 4335-4339Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.04.072
Keywords
Conjugate vaccines; CRM197; Pediatric vaccines
Categories
Funding
- Novartis Vaccines
Ask authors/readers for more resources
Glycoconjugate vaccines have been proven safe and effective against various diseases in children. Although these vaccines have a history of effectiveness, there are still many unanswered questions to be addressed, including conjugate interference when multiple vaccines are administered at one time, expansion of serotype coverage, effectiveness in special populations, and issues relating to conjugate vaccine use in the developing world. This paper focuses on the use of CRM197 as a carrier protein, contrasting it to other carrier proteins used in single-antigen pediatric vaccines as well as identifying areas for future study. (C) 2010 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available